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ABSTRACT
Objectives To determine the prevalence and causes of 
blindness and vision impairment, and the coverage and 
quality of cataract surgical services, among population 
aged 50 years and older in Sohag governorate in Egypt.
Design A population- based cross- sectional survey using 
two- stage cluster random sampling following the rapid 
assessment of avoidable blindness methodology.
Setting A community- based survey conducted by six 
teams of ophthalmologists, assistants and local guides. 
Enrolment and examination were door- to- door in selected 
clusters.
Participants Using 2016 census data, 68 population units 
were randomly selected as clusters (of 60 people) with 
probability proportionate to population size. Anyone aged 
50 years and older, residing in a non- institutional setting in 
a cluster for at least 6 months, was eligible to participate.
Primary and secondary outcome measures The 
prevalence and causes of blindness and vision impairment. 
Secondary outcomes were CSC and effectiveness and 
participant- reported barriers to cataract surgery.
Results Of 4078 participants enrolled, 4033 (98.9%) were 
examined. The age- adjusted and sex- adjusted prevalence 
of blindness, severe vision impairment and moderate 
vision impairment were 5.9% (95% CI 4.8% to 6.9%), 
4.7% (95% CI 3.8% to 5.7%) and 18.9% (95% CI 16.8% 
to 21.0%), respectively. Cataract caused most of blindness 
(41.6%), followed by non- trachomatous corneal opacity 
(15.7%) and posterior segment diseases (14.5%). Cataract 
surgical coverage (CSC) for persons for visual acuity <3/60 
was 86.8%, the proportion of cataract surgeries with poor 
visual outcome was 29.5% and effective CSC (eCSC) was 
44.9%. eCSC was lower in women than men. The most 
frequently reported barrier to surgery was cost (51.5%).
Conclusions The prevalence of blindness in Sohag 
governorate is higher than districts in other middle- income 
countries in the region. CSC was high; however, women 
suffer worse quality- corrected CSC than men. The quality 
of cataract surgery needs to be addressed, while health 
system strengthening across government and private 
settings could alleviate financial barriers.
INTRODUCTION
In 2018, over 23 million people had vision 
impaired in the Eastern Mediterranean 
Region (EMR), of whom 5 million were 
blind.1 Egypt is the most populous country 
in the Middle East with more than 98 million 
residents.2 It is classified as a low- middle 
income country (LMIC), with a gross 
domestic product per capita of $2549 in 
2018. The government allocated 4.2% of its 
total expenditure to health in 2016, while out 
of pocket payments constituted 62% of all 
health expenditure.3 Sohag governorate lies 
in the centre of Upper Egypt, the region with 
the highest levels of poverty in the country.4
There are four government hospitals 
(including one teaching hospital) and many 
private centres that provide eye care services 
to approximately five million citizens.5 
Across these facilities, 81 ophthalmologists 
carried out 5344 cataract operations—mainly 
phacoemulsification—in 2014, corresponding 
to a cataract surgical rate of 1161 per million 
population compared with 3674 per million 
population nationally.6 Phacoemulsification 
is a standard practice in private settings, while 
government hospitals use extracapsular cata-
ract extraction (ECCE) with intraocular lens 
implantation, due to cost considerations. 
Small incision cataract surgery is not known 
to be performed in either setting.6
Strengths and limitations of this study
 ► Addresses an overlooked area of research about the 
epidemiology of blindness in Egypt.
 ► Standardised cluster random sampling methodology 
and high response rate provides a representative 
sample of the population of interest.
 ► Analysis includes population- reported barriers to 
cataract surgery and insight on the coverage and 
quality of cataract services provided in the district.
 ► The rapid survey methodology may have underes-
timated the contribution of posterior segment con-
ditions to the burden of vision impairment in the 
governorate.
 ► The estimate of uncorrected presbyopia in the sam-
ple was based on an assumption that all participants 
were presbyopic and as such may overestimate the 
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Since the 1960s, there have been very few population- 
based, representative surveys of vision impairment in 
Egypt.7 A survey of the population 50 years and older in 
Menofiya governorate found a prevalence of blindness of 
7.9%.8 9 In 2010, the Ministry of Health and Population 
(MOHP) carried out surveys of the population 50 years 
and older in five governorates; however, data were not 
published. There are discrepancies between national and 
international vision impairment (VI) data. In 2017, the 
Central Agency for Public Mobilization and Statistics esti-
mated the all- age prevalence of blindness to be 0.57%,5 
while the International Agency for Blindness Prevention 
estimated it to be 0.96% for 2015.10 The reason for this 
inconsistency is unclear.
Over the years, gender inequality has been a key 
finding of blindness and eye health studies in Egypt,7 11 12 
all found approximately twice as many blind women as 
blind men in their samples. Egypt lacks a national plan 
for eye care. In the era of universal health coverage, it 
is important that eye health planners develop plans to 
achieve universal eye health—delivering equitable, high- 
quality services and improve quality of life for everyone 
affected by vision loss.
The objectives of this study were to determine the prev-
alence and causes of blindness and vision impairment in 
the population 50 years and older in Sohag governorate, 
and to report the coverage and quality of cataract surgical 
services, barriers to cataract surgery, as well as the preva-
lence of diabetes and diabetic retinopathy. The MOHP 
will use the data to develop a community- based eye care 
plan.
METHODS
A population- based, cross- sectional survey was conducted 
following the standardised rapid assessment of avoidable 
blindness (RAAB) methodology, with the addition of the 
diabetic retinopathy module.13 Results of the diabetic 
retinopathy component will be prepared for publication 
separately.
Sampling
The 2016 national census for Sohag governorate showed 
the population 50 years and older was 627 510.5 The 
sample size, calculated using RAAB6 software, was 4080 
individuals, based on an expected prevalence of diabetic 
retinopathy of 4.25% (25% of the prevalence of diabetes in 
adults in Egypt,14 with a precision of 20% of the expected 
prevalence, at 95% confidence level, non- compliance rate 
of 15% and a design effect of 1.6 to compensate for clus-
tering. The prevalence of diabetic retinopathy was used 
instead of blindness as it was expected to be the lower of 
the two values.
The sampling frame consisted of 288 urban and rural 
population units, corresponding to 12 Marakez (districts), 
based on 2016 census enumeration areas. From this, 68 
clusters were selected with probability proportionate to 
population size. Cluster selection was carried out using 
the RAAB6 software. Individuals within a population unit 
were selected through compact segment sampling. Each 
population unit was divided into equal segments esti-
mated to contain at least 60 people 50 years and older. 
For large population units, this was done with a grid 
square overlaid on a Google Maps map of the area. Local 
community leaders contributed to ensure all segments 
represented inhabited areas only and one segment was 
randomly selected for the survey. There was little vari-
ation in the arrangement of households between areas 
defined as urban or rural and most housing was single 
story. Households in a randomly selected segment were 
included in the survey until 60 people aged 50 years and 
older were enrolled. The study used a cluster size of 60 
instead of 50 as this was a ‘RAAB + Diabetic Retinop-
athy’ survey. In each selected segment, people 50 years 
and older, residing in non- institutional households for 
6 months or more over the past year, were eligible to 
participate.
Survey teams
There were six survey teams, each consisting of an ophthal-
mologist, ophthalmology assistant and local community 
worker. The six ophthalmologists were masters degree 
qualified, government employees from Cairo (four), 
Hurghada and Sohag (one each); all were part of the 
Magrabi Foundation outreach team. Teams were trained 
by a certified RAAB trainer and passed an interobserver 
variation test with a kappa score of at least 0.6 prior to the 
fieldwork.
Examination protocol
Presenting visual acuity (PVA) for right and left eyes was 
measured in ambient illumination, with a 6/60 tumbling 
E optotype at 6 m, 3 m or 1 m, and 6/18 and 6/12 tumbling 
E optotypes at 6 m. Pinhole VA was measured where 
presenting VA was <6/12 in any eye. All participants had 
a lens examination by an ophthalmologist using direct 
ophthalmoscope. Fundus examination using a direct and 
indirect ophthalmoscope was undertaken by an ophthal-
mologist to determine the cause of presenting VA <6/12 
as required. Dilated fundus examination, using two drops 
of tropicamide 0.5%, was carried out where the cause of 
vision impairment was not uncorrected refractive error, 
or an obvious corneal or lens opacity (or in line with the 
RAAB diabetic retinopathy module protocol). Glaucoma 
was considered the cause of vision impairment or blind-
ness based on only obvious pathological signs (digital 
palpation, an afferent pupil defect, corneal oedema, a 
vertical cup–disc ratio of 0.8 or greater) in the absence of 
intraocular pressure or visual field examination, or where 
an existing diagnosis of glaucoma was known. Details of 
the diabetic retinopathy examination protocol under-
taken will be reported in detail elsewhere.
WHO definitions of vision impairment and blindness, 
based on presenting VA in the better eye, were used. 
Blindness is VA less than 3/60, severe vision impairment 





ctober 13, 2020 at LSHTM




pen: first published as 10.1136/bmjopen-2019-036337 on 12 October 2020. Downloaded from 
3AlSawahli H, et al. BMJ Open 2020;10:e036337. doi:10.1136/bmjopen-2019-036337
Open access
vision impairment (MVI) is VA 6/60 or better and less 
than 6/18 and early vision impairment (EVI) is VA 6/18 
or better and less than 6/12.
Cataract surgical coverage (CSC) is an indicator of 
to what extent a population’s need for cataract surgery 
has been met. It is the number of people with operated 
cataract as a proportion of those with operated and oper-
able cataract, for a given level of cataract vision impair-
ment. Effective CSC (eCSC) reports the same proportion; 
however, it only includes the number of people with oper-
ated cataract that have achieved a good visual outcome 
(ie, can see 6/18 or better) in the numerator. As such, 
it is a measure of cataract surgical quality in addition to 
CSC.15
Refractive error includes people who presented with 
distance spectacles plus those whose VA improved from 
less than 6/12 presenting VA to 6/12 with pinhole. 
Uncorrected refractive error is the latter group only. 
Uncorrected presbyopia is defined as all examined 
people (aged 50 years and older) reporting not having 
near vision correction. Near VA is not measured in RAAB 
surveys.
Data collection and statistical analysis
Field work was completed over 23 days in February 2019. 
Two teams attended one cluster per day, examining 30 
participants each.
Data were collected door- to- door following the 
standardised RAAB6 two- page survey form and cross- 
checked daily to identify missing data and correct 
errors. Survey teams revisited enrolled participants 
who were not available at the first visit. Two data entry 
clerks used the RAAB6 software for consistency checks 
during data entry. Standardised survey reports were 
generated by RAAB6 software, which accounts for the 
clustered survey design. Adjusted prevalence estimates 
were weighted to age and sex disaggregated population 
data from the 2016 census. A two- sample test of propor-
tions was used in STATA V.16 software to compare the 
age- adjusted and sex- adjusted prevalences of blindness 
and vision impairment in men and women. This was a 
post hoc analysis, using data modified from RAAB’s stan-
dardised reporting output.
Participants and public involvement in the research
We did not directly include participants in the design 
of the research; however, policy makers in the MOHP 
and local community leaders were consulted about the 
survey design, questionnaire and approaches to facilitate 
the implementation of the study. In partnership with the 
MOHP, we will disseminate a plain language summary of 
the findings to the public.
RESULTS
Age and gender distribution
Among the 4078 people aged 50 years and older enrolled, 
13 were unavailable for examination (0.3%), 18 refused 
to be examined (0.4%) and 14 were not able to commu-
nicate (0.4%). Accordingly, a total of 4033 participants 
aged 50+ were examined, a response rate of 98.9%. The 
proportion of men in the sample was higher than the 
population (59.2% and 52.1%, respectively); there was 
a statistically significant difference in the proportions of 
the male and female population included in the sample 
(0.73% vs 0.55% [p<0.001; two- sample test of propor-
tions]). The youngest age group (50–59) was under- 
represented in the sample in contrast to the three older 
age groups. The difference between the sample popula-
tion and the study area is presented in table 1.
Blindness and vision impairment by gender
The age- adjusted and sex- adjusted prevalence of blind-
ness, SVI and MVI were 5.9% (95% CI 4.8% to 6.9%), 
4.7% (95% CI 3.8% to 5.7%) and 18.9% (95% CI 16.8% 
to 21.0%), respectively. There was only weak evidence of 
a statistically significant difference between women and 
men for blindness (p=0.046), but strong evidence for the 
differences between women and men for SVI and MVI 
(p<0.001 for both). The prevalence of early VI was 17.8% 
(95% CI 16.0% to 19.5%) with no evidence of a differ-
ence between sexes (p=0.151). (table 2).
Causes of blindness and VI
Cataract was the main cause of blindness (41.2%) 
followed by non- trachomatous corneal opacity (15.7%), 
and posterior segment diseases (14.5%). Glaucoma was 
responsible for 8.2% of blindness, while cataract surgical 
complications were responsible for 7.8% of blindness 
Table 1 Age and sex distribution of survey participants compared with the 2016 census data for Sohag governorate
Men Women Total
Sample Governorate Sample Governorate Sample Governorate
n % n % n % n % n % n %
50–59 995 41.6 168 208 51.4 731 44.5 157 701 52.5 1726 42.8 325 909 51.9
60–69 846 35.4 103 632 31.7 568 34.5 90 387 30.1 1414 35.1 194 019 30.9
70–79 411 17.2 39 858 12.2 261 15.9 37 423 12.5 672 16.7 77 281 12.3
80+ 137 5.7 15 268 4.7 84 5.1 15 033 5.0 221 5.5 30 301 4.8
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in the sample (table 3). Accordingly, 74.9% of causes 
of blindness were avoidable through either treatment 
or prevention. Non- trachomatous corneal opacity is not 
classified further by specific corneal disorders in the 
RAAB methodology. Onchocerciasis is not endemic in 
Egypt; however, a single case of onchocerciasis blindness 
was recorded in a man previously resident in Sudan, now 
living in the Sohag governorate.
84.5% of SVI was avoidable; 62.0% was treatable (60.5% 
due to cataract and 1.5% due to refractive error), while 
preventable causes (cataract surgical complications, 
glaucoma, diabetic retinopathy, trachomatous and non- 
trachomatous corneal opacities) together constituted 
22.5%.
Uncorrected refractive error contributed little to the 
prevalence of blindness, SVI or MVI but was the main 
cause of EVI (53.6%). 17.1% of the sample had refrac-
tive error, the majority of which was uncorrected (73.7%). 
The estimated proportion of the sample with uncorrected 
presbyopia was 95.5%.
Cataract blindness and vision impairment
The age- adjusted and sex- adjusted prevalence of bilat-
eral blindness with correction due to cataract (defined as 
pinhole VA less than 3/60 in both eyes with obvious lens 
opacity in both eyes) was 1.5% (95% CI 1.1% to 2.0%), 
with no difference between men and women (1.5% (95% 
Table 2 Age- adjusted and sex- adjusted prevalence of bilateral blindness, SVI, MVI and EVI, and the projected number of 







50 years and 




50 years and 




50 years and 
older % (95% CI)
Blindness 16 115 4.9 (3.9 to 6.0) 20 598 6.9 (5.1 to 8.6) 0.046 36 715 5.9 (4.8 to 6.9)
SVI 10 459 3.2 (2.4 to 4.0) 19 173 6.4 (4.7 to 8.0) <0.001 29 639 4.7 (3.8 to 5.7)
MVI 52 089 15.9 (13.5 to 18.3) 66 348 22.1 (19.7 to 24.5) <0.001 118 446 18.9 (16.8 to 21.0)
EVI 54 664 16.7 (14.6 to 18.8) 56 792 18.9 (16.8 to 21.0) 0.151 111 452 17.8 (16.0 to 19.5)
*Two- sample test of proportions using the adjusted prevalence estimates for male and female subgroups.
EVI, early vision impairment; MVI, moderate vision impairment; SVI, severe vision impairment.
Table 3 Causes of blindness, SVI, MVI and EVI based on participants’ presenting VA
Blindness Severe VI Moderate VI Early VI
n % n % n % n %
Refractive error 1 0.4 3 1.5 109 13.6 394 53.6
Aphakia, uncorrected 0 0 0 0 0 0 0 0
Cataract, untreated 105 41.2 121 60.5 366 45.8 151 20.5
Cataract surgical complications 20 7.8 20 10 53 6.6 23 3.1
Trachomatous corneal opacity 2 0.8 3 1.5 11 1.4 6 0.8
Non- trachomatous corneal opacity 40 15.7 14 7 34 4.3 11 1.5
Phthisis 0 0 0 0 0 0 0 0
Onchocerciasis 1 0.4 0 0 0 0 0 0
Glaucoma 21 8.2 4 2 12 1.5 7 1
Diabetic retinopathy 1 0.4 4 2 14 1.8 5 0.7
Age Related Macular Degeneration 
 (ARMD)
5 2 3 1.5 9 1.1 4 0.5
Other posterior segment disease 37 14.5 25 12.5 183 22.9 121 16.5
All other globe/Central Nervous 
System 
(CNS) abnormalities
22 8.6 3 1.5 9 1.1 13 1.8
Total 255 100 200 100 800 100 735 100
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CI 0.9% to 2.0%) and 1.6% (95% CI 0.8% to 2.4%), 
respectively (table 4).
The age- adjusted and sex- adjusted prevalence of unilat-
eral cataract blindness was 6.8% (95% CI 6.1% to 7.6%), 
with more women (8.4% (95% CI 7.1% to 9.7%)) affected 
than men (5.4% (95% CI 4.5% to 6.3%)).
Effective CSC
The CSC (in persons) for operable cataract causing 
VA<3/60 was 86.8%. The figure was similar in women 
(89.2%) and men (84.3%). CSC for VA<6/60 and <6/18 
were 79.3% and 61.2%, respectively, with slightly higher 
coverage in women than men for both (80.6% vs 77.9% 
and 63.0% vs 59.5%, respectively). eCSC was approxi-
mately half that of the CSC for the sample and, in contrast 
to CSC, effective coverage was higher in men than women 
at all three levels of vision (table 5).
Cataract surgical outcome
99.2% of all operated eyes were pseudophakic, with 
most surgeries done in private (66.0%) or government 
(24.3%) hospitals.
Considering presenting VA, visual outcome was good 
(≥6/18) in 46.1%, borderline (<6/18 to 6/60) in 25.6% 
and poor (<6/60) in 28.3% of operated eyes. Poor 
outcomes occurred in 25.1% of eyes in men and 31.8% 
of eyes in women.
Poor patient selection (eg, presence of comorbidities) 
and surgical complications were the most common causes 
of poor (58.0% and 32.1%, respectively) and borderline 
(44.9% and 30.2%) visual outcomes. With pinhole correc-
tion, the proportions of eyes with good, borderline and 
poor surgical outcomes were 55.4%, 20.9% and 23.8%, 
respectively; 48.8% of eyes with a presenting VA of 6/18 
but not 6/12 would benefit from distance spectacles, 
based on an observed improvement with pinhole.
Visual outcome was more favourable for eyes oper-
ated in private hospitals than charitable or faith- based 
organisations and government sites; good outcomes 
were achieved in 52.5% of eyes compared with 43.8% 
and 30.4%, respectively. Almost half of eyes operated at 
government hospitals (44.1%) had poor postoperative 
VA (<6/60). The proportion of eyes operated at govern-
ment hospitals was similar in men and women (26.0% 
and 22.3%, respectively).
For all operated eyes, visual outcomes were slightly 
better with more recent surgery. Good outcomes were 
achieved in 50.1% of operations in the past 3 years, drop-
ping to 42.7% in 4–6 years previously and 43.9% in 7 or 
more years ago. Poor outcomes had reduced over the 
same time periods.
Barriers to cataract surgery
Among people with bilateral cataract and best- corrected 
VA <6/60, the most frequently reported barrier to surgery 
was cost (51.5%), followed by ‘need not felt’ (28.7%). A 
slightly lower proportion of women than men reported 
cost as a barrier (47.7% and 54.9%, respectively).
DISCUSSION
The survey had a high response rate (98.9%). This was 
achieved as the survey teams revisited participants who 
were eligible but unavailable at first visit. Women and 
younger ages (50–59) were under- represented rela-
tive to the proportions available from the census data. 
Consequently, we reported age- adjusted and sex- adjusted 
estimates where available from the standardised survey 
analysis. The rapid survey methodology may have underes-
timated the contribution of posterior segment conditions 
to the burden of vision impairment in the governorate.16 
Table 5 CSC and effective CSC (in persons) by level of 
vision impairment due to operable cataract
Men (%) Women (%) Total (%)
CSC
  VA <3/60 83.4 89.2 86.6
  VA <6/60 77.9 80.6 79.3
  VA <6/18 59.5 63 61.2
Effective CSC
  VA <3/60 51 39 44.9
  VA <6/60 45.9 34.9 40.4
  VA <6/18 33.9 26.1 30.2
CSC, cataract surgical coverage; VA, visual acuity.
Table 4 Age- adjusted and sex- adjusted prevalence of bilateral cataract blindness, SVI, MVI and EVI (with best corrected VA) 
and the projected number of people aged 50 years and older affected in Sohag governorate
Men Women Total
Projected number 
of people aged 50 
years and older % (95% CI)
Projected number 
of people aged 50 
years and older % (95% CI)
Projected number 
of people aged 50 
years and older % (95% CI)
Blindness 4808 1.5 (0.9 to 2.0) 4750 1.6 (0.8 to 2.4) 9558 1.5 (1.0 to 2.0)
SVI 3043 0.9 (0.5 to 1.4) 5332 1.8 (1.0 to 2.5) 8375 1.3 (0.9 to 1.8)
MVI 15 636 4.8 (3.6 to 5.9) 17 761 5.9 (4.6 to 7.2) 33 397 5.3 (4.3 to 6.3)
EVI 11 745 1.8 (0.7 to 2.9) 10 992 1.8 (0.7 to 2.9) 22 737 1.8 (1.0 to 2.7)
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Uncorrected presbyopia may be overestimated in this 
study as the methodology assumes all participants require 
presbyopic correction. A previous study from Tanzania 
has suggested not all people aged 50 years and older are 
in fact presbyopic.17 Near spectacle use was self- reported 
and, as such, may be under- reported or over- reported.
The age- adjusted and sex- adjusted prevalence of blind-
ness in the population 50 years and older in Sohag gover-
norate was 5.9% (95% CI 4.8% to 6.9%). This area shares 
many demographic and cultural characteristics with the 
wider Upper Egypt region; however, we cannot generalise 
our findings too broadly. The most recent population- 
based estimate of blindness (PVA <3/60) for the same age 
group in Egypt was 7.9% in 2000 in Menofiya governorate 
in Nile delta. Compared with this finding, the point prev-
alence estimate of blindness in Egypt has decreased, but 
is higher than estimates from recent RAAB surveys in the 
region. Districts in upper- middle income countries, such as 
Libya, Iran and Jordan, have reported blindness estimates 
of 2.7%,18 1.9%19 and 1.2%,20 respectively. Our estimate was 
also higher than results from districts in other lower- middle 
income countries in the EMR region, for example, Sudan 
(4.9%) and Pakistan (4.2%).20 Only surveys in Sennar state, 
Sudan (2010) and Lahij and Amran governorates in Yemen 
(2009) found higher prevalence of blindness of 7.4%, 
10.8% and 9.3%, respectively.20 21
Cataract was the most common cause of blindness 
(41.2%), SVI (60.7%) and MVI (45.8%) overall, and 
in both men and women separately. This is in keeping 
with the survey in Menofiya in 2000 which also reported 
cataract as the main cause of ‘blindness’ (defined as VA 
<6/60, equivalent to SVI here) at 64%. CSC at that time 
was reported to be only 13%, although, at which level of 
vision impairment was not reported.
In Sohag, there are approximately 16 ophthalmolo-
gists per million people5 slightly lower than the WHO 
target for EMR of 20.22 At the national level, ophthal-
mologist density was estimated to be 65.6 per million in 
2015; however, only one third (24.6 per million) of these 
perform cataract surgery.22
The density of ophthalmologists in Egypt is higher 
than the neighbouring countries with lower prevalence 
of blindness. For example, Libya, Jordan and Iran had 
41.4, 44.8 and 21.5 ophthalmologists per million popu-
lations, respectively.23 Although ophthalmologist density 
may not necessarily be a strong predictor of blindness 
in a region,23 advancing the surgical capacity of the 
ophthalmic human resources available in Egypt should 
be a priority in efforts to reduce avoidable blindness. The 
distribution of cataract surgeons relative to population 
need should be reviewed and strategies to redress imbal-
ances may need to be considered.
The poor quality of cataract surgeries performed was an 
important contributor to the relatively high prevalence of 
blindness. Despite CSC for VA<3/60 reaching 90%, when 
eCSC (a measure of coverage and surgical quality) was 
considered, this dropped to 45%, and almost a quarter of 
cataract surgeries resulted in poor visual outcome, much 
higher than the WHO target of less than 5%.24 A review of 
cataract surgical training programmes and skills of trainees 
may be indicated to identify gaps in training contributing to 
poor surgical outcomes.
The higher prevalence of SVI and MVI among women 
compared with men was found to be statistically significant. 
There was only borderline statistical significance for the 
difference between the higher female blindness estimate 
compared with the male blindness estimate; however, this 
trend is consistent with previous studies in other gover-
norates in Egypt.11 12 Gender inequity in vision impair-
ment has often been reported to be a consequence of 
lower utilisation of eye care services by women than men.25 
Gender- specific barriers in this governorate may include 
the financial burden of seeking eye care, as Sohag has the 
highest rate of women who are the only source of income 
for their families (23.5%).26 Moreover, 53% of women in 
Sohag were not subscribed to, or beneficiaries of, health 
insurance compared with 47% for men in 2017.5
In this survey, cost and ‘need not felt’ were the most 
frequently reported barriers to surgery, similar to previous 
findings from LMIC.27 CSC was similar in women and men, 
suggesting that access to cataract surgical services was not 
affected by sex. However, when eCSC was considered, the 
coverage of quality cataract services was higher in men than 
women. Good outcomes were more likely at private hospi-
tals than government facilities; however, the proportion 
of eyes operated at each were similar in men and women. 
Women appears to suffer a cataract surgical quality deficit, 
but the reason for that is not clear from these data.
Although cataract surgery is provided at no or low 
cost at teaching and government hospitals, users tend to 
make out of pocket payments for private sector surgeries, 
even those who have insurance.28 Anecdotally, surgery at 
government hospitals may cost up to $50, while the cost 
of private surgery ranges from $250 to $500. The type of 
surgery and associated outcomes are an important influ-
ence on service utilisation. Phacoemulsification is typi-
cally offered at private facilities, unlike at government 
hospitals where ECCE is normally performed.6 A 2014 
study reported that, within the public sector, ophthalmol-
ogists felt there were a lack of training, supervision and 
incentives, while managers were concerned with a lack of 
government financial and technical support.6
While more cataract surgeries are needed to address the 
high prevalence of blindness, improving the proportion of 
good visual outcomes should occur in parallel. This may 
require investment in facilities and well- structured training 
programmes for government ophthalmologists. At the 
same time, as the private sector is a major service provider, 
partnerships and innovations in health financing can miti-
gate out of pocket expenditure on cataract surgery. Both 
government and private clinics will require ongoing moni-
toring of cataract surgical outcomes.29
Non- trachomatous corneal opacity was the second most 
common cause of blindness, followed by the other poste-
rior segment diseases and other globe or central nervous 
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causes of non- trachomatous corneal opacity are not avail-
able from this survey but merit further investigation as 
public health interventions for avoidable causes may be 
feasible. We found no other relevant literature on the 
causes of non- trachomatous corneal opacity in the popu-
lation in Egypt.
Only 17% of participants in the survey sample had 
refractive errors; however, 75% were uncorrected. As the 
main cause of mild VI, and considering the likely high 
burden of near vision impairment, further understanding 
of barriers to spectacle wear is warranted.
CONCLUSION
The prevalence of blindness in Sohag governorate in 
Egypt is higher than districts in other middle- income 
countries in the region. Most of the causes of blindness 
and vision impairment are avoidable. The gender gap in 
eye health remains a key issue to be considered by policy 
makers. Improvements in the quality of cataract surgery 
are required. Alongside further population- based studies 
of the prevalence and causes of blindness in Egypt, eye 
health system assessments should precede planning to 
better align services with the population need. Building 
on the capacities of government facilities is critical to 
increase the utilisation of services and provide quality, 
equitable eye care. Partnerships with private sector and 
civil society organisations can be an efficient tool to 
improve the affordability of the services.
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